GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 119,800
-7,100 (-5.59%)
Last updated: Jun 8, 2026, 2:03 PM KST
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.45 trillion as of June 5, 2026. Its market cap has increased by 6.64% in one year.
Market Cap
1.45T
Enterprise Value
2.40T
Revenue
2.04T
Ranking
n/a
PE Ratio
n/a
Stock Price
119,800.00
Market Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.45T, an increase of 4,879.50%. That is a compound annual growth rate of 13.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 1.45T | -20.19% |
| Dec 30, 2025 | 1.81T | -11.42% |
| Dec 30, 2024 | 2.05T | 43.03% |
| Dec 28, 2023 | 1.43T | -3.09% |
| Dec 29, 2022 | 1.48T | -40.60% |
| Dec 30, 2021 | 2.49T | -46.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hanall Biopharma | 2.94T |
| Celltrion Pharm | 1.93T |
| Daewoong Pharmaceutical | 1.39T |
| Chong Kun Dang Pharmaceutical | 980.30B |
| DongKook Pharmaceutical | 800.26B |
| Daewoong | 729.90B |
| Boryung | 705.41B |
| Ildong Pharmaceutical | 620.71B |